Table 1.
Fold Change in Steady-State Proinflammatory Transcript Expression in 3×Tg-AD Mice Injected with rAAV1-IFNγ versus rAAV1-eGFP at 10 Months Post-Transduction
Target Gene | Fold-change rAAV1-IFNγ- versus rAAV1-eGFP-infused 3×Tg-AD mice | SEM | P values for significance (Student t-test) |
---|---|---|---|
CCL2 (MCP-1) | 2.1399 | 0.3565 | <0.01 |
CCL3 (MIP-1α) | 1.8079 | 0.1982 | <0.01 |
CCL6 (MRP-1) | 1.8787 | 0.0937 | <0.001 |
TNF-α | 2.9663 | 0.6033 | <0.01 |
TNFrsf1a | 1.4606 | 0.0754 | <0.001 |
TNFrsf1b | 1.4793 | 0.1261 | <0.01 |
C3 | −1.5346 | 0.1436 | <0.05 |
Jun | 1.8071 | 0.0673 | <0.001 |
NFκb2 | 2.2097 | 0.1907 | <0.001 |
Transcriptional analysis of 3×Tg-AD mice injected with rAAV1-eGFP or rAAV1-IFNγ for additional proinflammatory markers of interest. Total RNA was purified from microdissected hippocampus from 12-month-old 3×Tg-AD mice that had been previously stereotactically infused with rAAV1-IFNγ or rAAV1-eGFP. cDNA pools were generated and subjected to Applied Biosystems Microfluidic Card analysis of additional inflammation-related transcriptional targets. Fold changes in steady-state transcript levels in rAAV1-IFNγ- versus rAAV1-eGFP-injected animals were calculated with SEM and subsequently tested for significance by Student’s t-test.